This inventor holds 8 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Fmc Biopolymer as, Fmc Corporation. Active years: 2010-2016.
Company Filing History:
Years Active: 2010-2016
Title: Innovations by Jan Egil Melvik
Introduction
Jan Egil Melvik is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of biopolymers, particularly in the development of self-gelling alginate systems. With a total of 8 patents, his work has advanced various biomedical applications.
Latest Patents
One of Melvik's latest patents is focused on self-gelling alginate systems and their uses. This invention includes kits and compositions for producing an alginate gel, which comprises soluble alginate and insoluble alginate/gelling ion particles. The methods disclosed involve forming a dispersion of these particles in a solution containing soluble alginate, which can then be dispensed to create an alginate gel matrix. Notably, the alginate gel can have a thickness greater than 5 mm and is designed to be free of certain additives such as sulfates and phosphates. Additionally, he has developed methods to improve the viability of pancreatic islets and other cellular aggregates during storage and transport. Another significant invention relates to gelled composites that incorporate a polysaccharide gel within foam pores, which can be utilized in various applications, including biomedical, food, and personal care sectors.
Career Highlights
Throughout his career, Jan Egil Melvik has worked with prominent companies such as Fmc Biopolymer AS and Fmc Corporation. His expertise in biopolymers has allowed him to contribute to innovative solutions in the industry.
Collaborations
Melvik has collaborated with notable colleagues, including Michael Dornish and Terje Svendsen, enhancing the impact of his inventions through teamwork and shared expertise.
Conclusion
Jan Egil Melvik's contributions to the field of biopolymers and his innovative patents demonstrate his commitment to advancing technology in biomedical applications. His work continues to influence various industries and improve the viability of critical biological components.